US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
イギリス
LSE
Sandoz Group Ag (0SAN)
Sandoz Group Ag (0SAN) ニュース

0SAN

Sandoz (0SAN)

Sandoz Group Ag

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0SAN

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	14 : 00	UK Regulatory	Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe	LSE:0SAN	Sandoz Group Ag
2024/05/07	14 : 00	UK Regulatory	Sandoz reports first quarter 2024 sales	LSE:0SAN	Sandoz Group Ag
2024/04/30	19 : 25	UK Regulatory	Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG	LSE:0SAN	Sandoz Group Ag
2024/04/30	14 : 00	UK Regulatory	Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars	LSE:0SAN	Sandoz Group Ag
2024/04/22	14 : 00	UK Regulatory	Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering	LSE:0SAN	Sandoz Group Ag
2024/03/21	22 : 00	UK Regulatory	Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines	LSE:0SAN	Sandoz Group Ag
2024/03/13	15 : 00	UK Regulatory	Sandoz reports fourth quarter 2023 sales and full-year 2023 results	LSE:0SAN	Sandoz Group Ag
2024/03/06	03 : 24	UK Regulatory	Sandoz receives FDA approval for first and only denosumab biosimilars	LSE:0SAN	Sandoz Group Ag
2024/03/05	15 : 00	UK Regulatory	Sandoz announces nominations to the Board of Directors and leadership change	LSE:0SAN	Sandoz Group Ag
2024/03/04	15 : 00	UK Regulatory	Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market	LSE:0SAN	Sandoz Group Ag
2024/02/29	15 : 00	UK Regulatory	Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs	LSE:0SAN	Sandoz Group Ag
2024/02/01	15 : 15	UK Regulatory	Sandoz announces changes in the Board of Directors	LSE:0SAN	Sandoz Group Ag
2024/01/31	15 : 00	UK Regulatory	Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany	LSE:0SAN	Sandoz Group Ag

Showing the most relevant articles for your search:LSE:0SAN

1

JP Morgan Chase

Invesco QQQ Trust Series 1

Health Care Select Sector

American Express

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約